**AI医学影像创新企业「深智透医」成功斩获近千万美元B+轮融资**
近日，全球领先的AI医学影像公司「深智透医」（Subtle Medical Inc.，简称“深透”）宣布已完成B+轮近千万美元的融资，进一步巩固了其在医疗人工智能领域的领先地位。此轮融资由深透的现有股东Fusion Fund领投，新晋投资方包括嘉加资本（ENVISIONX Capital）、蓝驰创投硅谷总部基金Bluerun Ventures、上海文周投资以及亚太地区的一系列战略合作方共同参与。
资金的注入将主要用于推动深智透医的AI产品在全球范围内的商业化进程，同时加大研发投入，以持续创新并优化其医疗影像分析技术。深智透医以其先进的算法和精准的影像分析能力，已经在医疗影像诊断领域取得了显著的成果，此次融资将有助于其技术更广泛地服务于全球医疗机构，提升医疗服务的效率和质量。
深智透医的创始人兼CEO表示，公司将继续致力于利用人工智能技术改善医疗影像的诊断准确性和效率，为全球的医生和患者提供更高效、更精准的医疗解决方案。此轮融资的顺利完成，标志着深智透医在AI医学影像领域的探索与实践得到了资本市场的广泛认可，也预示着公司在全球医疗AI市场的发展将步入新的阶段。
随着医疗科技的不断进步，AI在医学影像分析中的应用日益凸显，深智透医的创新技术有望在全球范围内引领行业变革，为医疗健康领域带来重大影响。
英语如下：
**News Title:** “Subtle Medical Secures Million-Dollar B+ Round Investment, Accelerating Global AI Medical Imaging Expansion”
**Keywords:** AI Medical Imaging, Subtle Medical, Million-Dollar Financing
**News Content:**
Recently, Subtle Medical Inc. (“Subtle” for short), a global leader in AI medical imaging, announced the completion of a B+ round financing of nearly $10 million, further solidifying its position at the forefront of the medical artificial intelligence sector. This round was led by existing shareholder Fusion Fund, with new investors including ENVISIONX Capital, Bluerun Ventures (the Silicon Valley-based fund of BlueRun Ventures), Shanghai Wen Zhou Investment, and a series of strategic partners from the Asia-Pacific region.
The funds will primarily be used to drive the global commercialization of Subtle Medical’s AI products and increase research and development efforts to continuously innovate and optimize its medical image analysis technology. With its advanced algorithms and precise image analysis capabilities, the company has already made significant strides in medical imaging diagnosis. This financing will enable its technology to serve a broader range of global healthcare institutions, enhancing the efficiency and quality of healthcare services.
The founder and CEO of Subtle Medical stated that the company will continue to dedicate itself to improving the accuracy and efficiency of medical imaging diagnosis through artificial intelligence, offering more efficient and precise healthcare solutions to doctors and patients worldwide. The successful completion of this funding round signifies widespread recognition of Subtle Medical’s explorations and practices in AI medical imaging by the capital market and forecasts a new phase of development for the company in the global medical AI market.
As medical technology advances, the application of AI in medical image analysis is becoming increasingly prominent. Subtle Medical’s innovative technology is poised to drive industry transformation globally, exerting a significant impact on the healthcare sector.
【来源】https://36kr.com/p/2771350743743239
Views: 1